Chrysin serves as a novel inhibitor of DGK alpha/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)

Chen, J; Wang, Y; Zhao, D; Zhang, LY; Zhang, WM; Fan, JW; Li, JT; Zhan, QM

Zhan, QM (corresponding author), Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Lab Mol Oncol, Beijing 100142, Peoples R China.

ACTA PHARMACEUTICA SINICA B, 2021; 11 (1): 143